CAR T for CNS lymphoma: Early research shows promise
December 12, 2018 | Cara Martinez
Xiuli Wang, Ph.D., research professor at City of Hope, presented encouraging research on using CAR T cell therapy for central nervous system lymphoma at this year's American Society of Hematology conference.
City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting
December 5, 2018 | Letisia Marquez
Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.
Lucy’s Story: Immunotherapy Trial Gives Lymphoma Patient New Hope
July 19, 2018 | Dory Benford
After many complications, City of Hope lymphoma patient Lucy found renewed hope after an immunotherapy clinical trial.
Surprising Diagnosis Leads Skin Cancer Patient to City of Hope
May 29, 2018 | Robert Young
Barbara Dorfman ran a large nursery school for 25 years, helped raise five children and has enjoyed an exceptionally active lifestyle with her husband, but nothing could prepare her for the diagnosis she received four years ago.
Patient with Rare Skin Cancer Grateful for City of Hope Dermatology Team
May 22, 2018 | Robert Young
When what he thought was just a rash on his forehead spread to his face and neck, Joshua Singer sought medical help. After a number of treatments failed to figure out the problem, he turned to City of Hope, and renowned dermatologist Christiane Querfeld. M.D., Ph.D.
The Many Types of Skin Cancer: What You Should Know
May 21, 2018 | Kevin Chesley
Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope Christiane Querfeld, M.D., Ph.D.